Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4009-4016

  Bérubé, Pierre ^a   Barbeau, Benoît ^a   Cantin, Réjean ^a   Sékaly, Rafick Pierre ^b,c   Tremblay, Michel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN CROSS LINKING; RECEPTOR DOWN REGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIGENS, CD4; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); NF-KAPPA B; SRC-FAMILY KINASES; TETRADECANOYLPHORBOL ACETATE;

EID: 0029949810     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Aguilar-Cordova, E., J. Chinen, L. Donehower, D. E. Lewis, and J. W. Belmont. 1994. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses 10:295-301.
2. Arya, S. K., C. Guo, O. Joseph, and F. Wong-Staal. 1985. Trans-activator gene of human T lymphotropic virus type III. Science 229:69-74.
3. Bank, I., and L. Chess. 1985. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 162:1294-1303.
4. Benkirane, M., P. Corbeau, V. Housset, and C. Devaux. 1993. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J. 12:4909-4921.
5. Benkirane, M., M. Hirn, D. Carrière, and C. Devaux. 1995. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J. Virol. 69:6898-6903.
6. Benkirane, M., K.-T. Jeang, and C. Devaux. 1994. The cytoplasmic domain of CD4 plays a critical role during the early stage of HIV infection in T-cells. EMBO J. 13:5559-5569.
7. Benkirane, M., H. Schmid-Antomarchi, D. R. Littman, M. Hirn, B. Rossi, and C. Devaux. 1995. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J. Virol. 69:6904-6910.
8. Bernier, R., and M. Tremblay. 1995. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J. Virol. 69:291-300.
9. Boulerice, F., S. Bour, R. Geleziunas, A. Lvovich, and M. A. Wainberg. 1990. High frequency of defective human immunodeficiency virus type 1 and heterogeneity of viral expression in clones of infected U937 cells. J. Virol. 64:1745-1755.
10. Burkly, L. C., D. Olson, R. Shapiro, G. Winkler, J. J. Rosa, D. W. Thomas, C. Williams, and P. Chisholm. 1992. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induccd cell fusion. J. Immunol. 149:1779-1787.
11. Caputo, A., J. G. Sodroski, and W. A. Haseltine. 1990. Constitutive expression of HIV-1 Tat protein in human Jurkat T cells using a BK virus vector. J. Acquired Immune Defic. Syndr. 3:372-379.
12. lck together with impairment of T cell activation. J. Immunol. 149:285-294.
13. Chimurle, N., V. S. Kalyanaraman, N. Oyaizu, H. B. Slack, and S. Pahwa. 1990. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 75:152-159.
14. Corbeau, P., M. Benkirane, R. Weil, C. David, S. Emiliani, D. Olive, C. Mawas, A. Serre, and C. Devanx. 1993. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J. Immunol. 150:290-301.
15. Cruikshank, W. W., D. M. Center, S. W. Pyle, and H. Kornfeld. 1990. Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking. Biomed. Pharmacother. 44:5-11.
16. Dalgleish, A. G., P. C. L. Beverly, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 312:763-767.
17. Diamond, D. C., B. P. Sleckman, T. Gregory, L. A. Lasky, J. L. Greenstein, and S. J. Burakoff. 1988. Inhibition of CD4+ T cell function by the HIV envelope protein. J. Immunol. 141:3715-3717.
18. Doyle, C., and J. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature (London) 330:256-259.
19. Eichmann, K., J. Jonsson, I. Falk, and F. Emmrich. 1987. Effective activation of resting mouse T lymphocyte by crosslinking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur. J. Immunol. 17:643-650.
20. Emmrich, F., L. Kantz, and K. Eichmann. 1987. Cross-linking of the T cell receptor complex with the subset-specific differentiation antigen stimulates interleukin 2 receptor expression in human CD4 and CD8 T cells. Eur. J. Immunol. 17:529-534.
21. Fields, A. P., D. P. Bednarik, A. Hess, and W. S. May. 1988. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature (London) 333:278-280.
22. Folks, T., D. M. Powell, M. M. Lightfoote, S. Benn, M. A. Martin, and A. S. Fauci. 1986. Induction of HTLV-III/LAV from a non virus-producing T-cell line: implications for latency. Science 231:600-602.
23. Gay, D. P., P. Maddon, R.-P. Sékaly, A. Talle, M. Godfrey, E. Long, G. Goldstein, L. Chess, R. Axel, J. Kappler, and P. Marrack. 1987. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature (London) 328:626-629.
24. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
25. Gelderblom, H. R., H. Reupke, and G. Pauli. 1985. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet ii:1016-1017.
26. Gelderblom, H. S. 1991. Assembly and morphology of HIV: potential effect of structure and viral function. AIDS 5:617-638.
27. Goldman, F., W. A. Jensen, G. L. Johnson, L. Heasly, and J. C. Cambier. 1994. gp120 ligation of CD4 induces activation and TCR desensitization independent of TCR tyrosine phosphorylation. J. Immunol. 153:2905-2917.
28. Goodenow, M., T. Huet, W. Saurin, S. Kwok, J. Sninsky, and S. Wain-Hobson. 1989. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. Acquired Immune Defic. Syndr. 2:344-352.
29. Haffar, O. K., P. A. Moran, M. D. Smithgall, M. L. Diegel, P. Sridhar, J. A. Ledbetter, J. M. Zarling, and S.-L. Hu. 1992. Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles. J. Virol. 66:4279-4287.
30. Harper, M. E., L. M. Marselle, R. C. Gallo, and F. Wong-Staal. 1986. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83:772-776.
31. Hasunuma, T., H. Tsubota, M. Watanabe, Z. W. Chen, C. I. Lord, L. C. Burkly, J. F. Daley, and N. L. Letvin. 1992. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J. Immunol. 148:1841-1846.
32. lck in human CD4 T lymphocytes. Eur. J. Immunol, 23:600-607.
33. Horak, I. D., M. Popovic, E. M. Horak, P. J. Lucas, R. E. Gress, C. H. June, and J. B. Bolen. 1990. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120. Nature (London) 348:557-560.
34. + T cells inhibits the binding activity of NF-AT, NF-κB and AP-I. three nuclear factors regulating interleukin-2 gene enhancer activity. Eur. J. Immunol. 24:2646-2652.
35. Janeway, C. A. 1989. The role of CD4 in T-cell activation: accessory molecule or co-receptor? Immunol. Today 10:234-238.
36. Julius, M., K. Newell, C. Maroun, and L. Haughn. 1991. Functional consequences of CD4-TCR/CD3 interactions. Semin. Immunol. 3:161-170.
37. lck with CD4 in human T lymphocytes. J. Biol. Chem. 266:11176-11183.
38. Kaufman, R., D. Laroche, K. Buchner, F. Hocho, C. Rudd, C. Lindchau, P. Ludwig, A. Hoer, E. Oberdisse, J. Kopp, I.-J. Korner, and H. Repke. 1992. The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction in T cells. J. Acquired Immune Defic. Syndr. 15:760-770.
39. Klatzman, D., E. Champagne, S. Chamarest, J. Gruest, D. Guetard, T. Hercend, J.-C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 312:767-768.
40. Koga, Y., N. Oh-Hori, H. Sato, N. Yamamoto, G. Kimura, and K. Nomoto. 1989. Absence of transcription of lck (lymphocyte specific protein-tyrosine kinase) message in IL-2-independent. HTLV-I-transformed T cell lines. J. Immunol. 142:4493-4499.
41. Kornfeld, H., W. W. Cruikshank, S. W. Pyle, J. S. Berman, and D. M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (London) 335:445-448.
42. Kupfer, A., S. J. Singer, C. A. Janeway, and S. L. Swain. 1987. Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting colls. Proc. Natl. Acad. Sci. USA 84:5888-5892.
43. Lasky, L., G. Nakamura, D. H. Smith, C. Fernie, C. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type I gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
44. Ledbelter, J. A., L. K. Gilliland, and G. L. Schieven. 1990. The interaction of CD4 with CD3/Ti regulates phosphorylation of substrates during T cell activation. Semin. Immunol. 2:99-106.
45. Ledbetter, J. A., C. H. June, L. S. Grosmaire, and P. S. Rabinovitch. 1987 Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in lymphocytes. Proc. Natl. Acad. Sci. USA 84:1384-1388.
46. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
47. Li, Y., J. C. Kappes, J. A. Conway, R. Price, G. M. Shaw, and B. H. Hahn. 1991. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective genomes. J. Virol. 65:3973-3985.
48. Linette, G. P., R. J. Hartzman, J. A. Ledbetter, and C. H. June. 1988. HIV-1-infected Tcells show a selective signaling defect after perturbation of CD3/anligen receptor. Science 241:573-576.
49. Luo, K., and B. M. Sefton. 1990. Cross-linking of T-ccll surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site. Mol. Cell. Biol. 10:5305-5313.
50. Mann, D. L., F. Lasane, M. Popovic, L. O. Arthur, W. Robey, W. A. Blattner, and M. J. Newman. 1987. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J. Immunol. 138:2640-2644.
51. Marrack, P., R. Endres, R. Shimonkewitz, A. Zlotnik, K. W. Dialynas, and J. Kappler. 1983. The major histocompatibility complex-restricted antigen receptor on T-cells: role of the L3T4 product. J. Exp. Med. 158:1077-1091.
52. McDougal, J. S., M. S. Kennedey, J. M. Sligh, S. P. Cort, A. Mawle, and J. K. Nicholson. 1986. Binding of HTLV-III/LAV toT4+ cells by a complex of the 110 kDa viral protein and the T4 molecule. Science 231:382-385.
53. McDougal, J. S., J. K. A. Nicholson, G. D. Cross, S. P. Cort, M. S. Kennedey, and A. C. Mawle. 1986. Binding of the human retrovirus HTLV-III/LAV/ ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. J. Immunol. 137:2937-2944.
54. Meyerhans, A., R. Cheynier, J. Albert, M. Selb, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjö, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-911.
55. Mittler, R. S., and M. K. Hoffman. 1989. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380-1382.
56. Moore, J. P., J. A. McKeating, Y. Huang, A. Ashkenazi, and D. D. Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:235-243.
57. Moscicki, R. A., E. P. Amento, S. M. Krane, J. T. Kurnick, and R. B. Cohin. 1983. Modulation of surface antigens of a human monocyte cell line, U937. during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytcs. J. Immunol. 131:743-748.
58. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T-cells. Nature (London) 326:711-713.
59. Neudorf, S. M. L., M. M. Jones, B. M. McCathy, J. A. K. Harmony, and E. Choi. 1990. The CD4 molecule transmits biochemical information important in the regulation of T lymphocyte activity. Cell. Immunol. 125:301-314.
60. 2+ influx or lead to activation of protein kinases. AIDS Res. Hum. Retroviruses 7:587-593.
61. Oyaizu, N., N. Chirmule, V. S. Kalyanaraman, W. W. Hall, R. A. Good, and S. Pahwa. 1990. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87:2379-2383.
62. + T-cell clones. J. Virol. 65:6277-6282.
63. Peterson, A., and B. Seed. 1988. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54:65-72.
64. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
65. Reinherz, E. L., and S. F. Schlossman. 1980. The differentiation and function of human T lymphocytes. Cell 19:821-827.
66. Rosoff, P. M., S. J. Burakoff, and J. L. Greenstein. 1987. The role of the L3T4 molecule in mitogen and antigen-activated signal transduction. Cell 49:845-853.
67. Schwartz, O., J.-L. Virelizier, L. Montagnier, and U. Hazan. 1990. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene 88:197-205.
68. Shaw, A. S., K. E. Amrein, D. F. Hammond, D. F. Stern, B. M. Sefton, and J. K. Rose. 1989. The lek tyrosine protein kinase interacts with the cytoplasmic tail of CD4 glycoprotein through its unique amino-terminal domain. Cell 59:627-636.
69. Sleckman, B. P., A. Peterson, W. K. Jones, J. A. Foran, J. L. Greenstein, B. Seed, and S. J. Burakoff. 1987. Expression and function of CD4 in a murine T-cell hybridoma. Nature (London) 328:351-353.
70. Smith, S. D., M. Shatsky, P. S. Cohen, R. Warnke, M. P. Link, and B. E. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant T lymphoid cells and derived cell lines. Cancer Res. 44:5657-5660.
71. Sodroski, J. G., R. Patarca, C. Rosen, F. Wong-Staal, and W. A. Haseltine. 1985. Location of the transactivation region on the genome of HTLV III. Science 229:74-77.
72. Swain, S. L. 1983. T cell subsets and the recognition of MHC class. Immunol. Rev. 74:129-142.
73. Terhorst, C., A. van Agthoven, E. Reinherz, and S. Schlossman. 1980. Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5. Science 209:520-521.
74. Tite, J. P., A. Sloan, and C. A. Janeway, Jr. 1986. The role of L3T4 in T cell activation: L3T4 may be both an 1a binding protein and a receptor that transduces a negative signal. J. Mol. Cell. Immunol. 2:179-187.
75. Tong-Starksen, S. E., P. A. Luciw, and M. B. Peterlin. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142:702-707.
76. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J. 13:774-783.
77. Tremblay, M., K. Numazaki, X. Li, M. Gornitsky, J. Hiscott, and M. A. Wainberg. 1990. Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infectcd patients is probably mediated by neutralizing antibodies. J. Immunol. 145:2896-2901.
78. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 60:755-765.
79. Wahl, L. M., M. L. Corcoran, S. W. Pyle, L. O. Arthur, A. Harel-Bellan, and W. L. Farrar. 1989. Human immunodeficiency virus glycoprotein (gp120): induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86:621-625.
80. Wassmer, P., C. Chan, L. Lodgdeberg, and E. M. Shevach. 1985. Role of the L3T4 antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells. J. Immunol. 135:2237-2242.
81. Willard-Gallo, K., F. Van de Keere, and R. Kettman. 1990. A specific defect inCD3-γgene transcription results in loss of T cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T cell line. Proc. Natl. Acad. Sci. USA 87:6713-6717.